Skip to main content

Table 2 Prevalence of MSI, KRAS and BRAF and associated LN yield rate.

From: Influence of Microsatellite Instability and KRAS and BRAF Mutations on Lymph Node Harvest in Stage I–III Colon Cancers

  

MSI

KRAS codon12 + 13

BRAF V600E

 

n

Prevalence

Node yielda

Prevalence

Node yielda

Prevalenceb

Node yielda

All

204

67 (33)

53 (79)

75 (37)

51 (68)

57 (28)

41 (72)

Stage I

40

17 (43)

12 (71)

17 (43)

8 (47)

12 (30)

8 (67)

Stage II

103

32 (31)

26 (81)

37 (36)

26 (70)

27 (27)

21 (78)

Stage III

61

18 (30)

15 (83)

21 (34)

17 (81)

18 (30)

12 (67)

  1. Data are n (%) or n.
  2. aNode yield, denotes the rate of patients with ≥12 nodes sampled after surgery
  3. bMissing data in one patient for BRAF mutation status.